1. Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180
- Author
-
Lucchese A., Di Stasio D., Borgia R., Scivetti M., Petruzzi M., Lucchese, A., Di Stasio, D., Borgia, R., Scivetti, M., and Petruzzi, M.
- Subjects
cross-reactivity ,Bullous pemphigoid ,SARS-Cov-2 ,autoimmunity ,BP180 ,molecular mimicry ,Covid-19 - Abstract
Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicry between the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further our understanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a high degree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.
- Published
- 2022